Riskpilot← Back to searchSign inGet full accessDosimera AB
ABActiveOrg 5593091274Bräckevägen 543Technical testing and analysis · NACE 7120Est. 20211 employees
Revenue 2025
SEK 46K
EBITDA margin
-290.7%
+88% vs 2024
Equity ratio
80.6%
Financial strength
Net profit 2025
SEK 25K
+102% vs 2024
| Revenue | SEK 46K | — |
| EBITDA | SEK -134K | +88% |
| Net profit | SEK 25K | +102% |
| Total assets | SEK 1,4M | +328% |
| Equity | SEK 1,2M | +203% |
| Employees | 1 | — |
Legal name
Dosimera AB
Org number
5593091274
Legal form
Aktiebolag
NACE code
7120 · Technical testing and analysis
Founded
25 mars 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att, direkt eller indirekt, bedriva övervakning av radioaktiv strålning, inklusive dosimetriverksamhet, samt att bedriva annan därmed förenlig verksamhet.
Address
Bräckevägen 543
Email
fredrik.nordwall@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 777 | 480 | 0 | 0 | 46 |
| Staff expenses | — | −368 | −0 | −394 | −535 |
| EBITDA | 5 | 69 | −6 | −1 148 | −134 |
| Depreciation & amort. | −0 | — | — | −2 | −125 |
| EBIT | 5 | 69 | −6 | −1 150 | −260 |
| Net financials | — | −0 | 0 | 0 | 0 |
| Profit before tax | 5 | 69 | −6 | −1 150 | −260 |
| Tax | −1 | −14 | — | — | 285 |
| Net profit | 4 | 54 | −6 | −1 150 | 25 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 115 | 91 | 25 | 337 | 1 444 |
| Equity | 29 | 83 | 20 | −1 131 | 1 165 |
| Long-term debt | 0 | — | — | 1 000 | 0 |
| Short-term debt | 86 | 8 | 5 | 468 | 280 |
| Total debt | 86 | 8 | 5 | 1 468 | 280 |
EBITDA margin
-290.7%
This company
15.8%
Market median
-1940% vs market
20212025
Equity ratio
80.6%
This company
38.2%
Market median
+111% vs market
20212025
Return on equity
2.2%
This company
18.4%
Market median
-88% vs market
20212025
Net profit margin
55.1%
This company
8.1%
Market median
+580% vs market
20212025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20212025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-03-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2024 – 2024 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dosimera AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Raymond Tage Cederqvist | Deputy Board Member | 0 companies |
| Karl Tobias Jakobsson | Deputy Board Member | 0 companies |
| Axel Fredrik Nordwall | Board of Directors | 0 companies |
| Lillemor Hult | Board of Directors | 0 companies |